Alfuzosine Sandoz 10 mg tabl. prol.-rel.

País: Bélgica

Idioma: inglés

Fuente: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredientes activos:

Alfuzosin Hydrochloride 10 mg

Disponible desde:

Sandoz SA-NV

Código ATC:

G04CA01

Designación común internacional (DCI):

Alfuzosin Hydrochloride

Dosis:

10 mg

formulario farmacéutico:

Prolonged-release tablet

Composición:

Alfuzosin Hydrochloride 10 mg

Vía de administración:

Oral use

Área terapéutica:

Alfuzosin

Resumen del producto:

CTI code: 294192-08 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-09 - Pack size: 180 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-04 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-05 - Pack size: 60 - Commercialisation status: YES - FMD code: 07613421000097 - CNK code: 2414944 - Delivery mode: Medical prescription; CTI code: 294192-06 - Pack size: 60 (60 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-07 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-02 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-03 - Pack size: 30 - Commercialisation status: YES - FMD code: 07613421000080 - CNK code: 2414969 - Delivery mode: Medical prescription

Estado de Autorización:

Commercialised: Yes

Fecha de autorización:

2007-04-16